“Impact of stature on non-communicable diseases: evidence based on Bangladesh Demographic and Health Survey, 2011 data”

BMC Public Health

Wasimul Bari¹  Mahfuzur Rahman Khokan¹  Md Erfanul Hoque¹ 

[1] Department of Statistics, Biostatistics & Informatics, University of Dhaka, Dhaka, 1000, Bangladesh

关键词: Stature;    Hypertension;    Diabetes;    Blood pressure;    Blood glucose level;   

Others  :  1126615
DOI  :  10.1186/1471-2458-14-1007

 received in 2014-03-02, accepted in 2014-09-16,  发布年份 2014

【 摘 要 】

Background

In this paper, an attempt has been made to explore the relationship between height and occurrence of the non-communicable diseases such as diabetes and hypertension.

Methods

For the purpose of analysis, Bangladesh Demographic and Health Survey (BDHS), 2011 data was used. Bivariate analysis along with a Chi-square test was performed to examine association between height and diseases. To measure the impact of stature on diabetes and hypertension, three different logistic regression models (Model I: considering only quartiles of height, Model II: covariates of model I along with demographic variables and Model III: covariates of model II along with clinical variable) were considered.

Results

Occurrence of diabetes and hypertension was found to be inversely related with the height of participants. This inverse association was statistically significant for all three models. After controlling the demographic and clinical variables simultaneously, the odds ratio for highest quartile compared to the lowest quartile was 0.82 with 95% confidence interval (0.69, 0.98) for diabetes; whereas it was 0.72 with 95% confidence interval (0.55, 0.95) for hypertension.

Conclusions

Findings of this paper indicate that persons with shorter stature are substantially more likely to develop diabetes as well as hypertension. The occurrence of non-communicable diseases like diabetes and hypertension can be reduced by controlling genetic and non-genetic (early-life and childhood) factors that may influence the height.

【 授权许可】

   
2014 Hoque et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization (WHO, 2010): Global Status Report on Non-communicable Diseases. Geneva: WHO; 2010.
• [2]Bangladesh Demographic Health Survey Report (BDHS). 2011.
• [3]World Health Organization (WHO, 2003): World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: WHO; 2003.
• [4]Centers for Disease Control and Prevention (CDC) and National Center for Chronic Disease Prevention and Health Promotion: The Power of Prevention: Chronic Disease: The Public Health Challenge of the 21st Century. Atlanta, GA: CDC; 2009. http://www.cdc.gov/chronicdisease/pdf/2009-Power-of-Prevention.pdf webcite
• [5]Zaman MM, Ahmed J, Chowdhury SR, Numan SM, Parvin K, Islam MS: Prevalence of Ischemic Heart Disease in a Rural Population of Bangladesh. Indian Heart J 2007, 59:239-41.
• [6]Karar ZA, Alam N, Streatfield PK: Epidemiological Transition in Rural Bangladesh,1986–2006. North America: Glob Health Action; 2009. http://www.globalhealthaction.net/index.php/gha/article/view/1904 webcite
• [7]Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Wel-born TA, Shaw JE: Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study. Diabet Med 2008, 25:296-302.
• [8]Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Kostense PJ, Yudkin JS, Heine RJ, Nijpels G, Seidell JC: Association of hip and thing circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn study. Am J Clin Nutr 2003, 77:1192-7.
• [9]Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F: Impact of hip circumference and height on incident diabetes: result from 6-year follow-up in the Tehran lipid and glucose study. Diabet Med 2011, 28:1330-6.
• [10]Wang SL, Pan WH, Hwu CM, Ho LT, Lo CH, Lin SL, Jong YS: Incidence of NIDDM and the effects of gender, obesity, and hyperinsulinaemia in Taiwan. Diabetologia 1997, 40:1431-8.
• [11]Njolstad I, Amesen E, Lund-Larsen PG: Sex-differences in risk factors for clinical diabetes mellitus in a general population: a 12-years follow-up of the Finnmark Study. Am J Epidemiol 1998, 147:49-58.
• [12]Lorenzo C, Williams K, Stern MP, Haffner SM: Height, ethnicity and the incidence of diabetes: the San Antonio Heart Study. Metabolism 2009, 58:1530-5.
• [13]Schulze MB, Heideman C, Schienkiewitz A, Bergmann MM, Hoffmann K, Boeing H: Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam Study. Diabetes Care 2006, 29:1921-3.
• [14]Olatunbosun ST, Bella AF: Relationship between height, glucose intolerance and hypertension in an urban African black adult population: A case for the “thrifty phenotype” hypertension? J Natl Med Assoc 2000, 92:265-8.
• [15]Christakis GT, Weisel RD, Buth KJ, Fremes SE, Rao V, Panagiotopoulos KP, Ivanov J, Goldman BS, David TE: Is body size the cause for poor outcomes of coronary artery bypass operations in women? J Thorac Cardiovasc Surg 1995, 110:1344-56. discussion 1356–8
• [16]Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE: Evidence that height is an independent risk factor for coronary artery disease (the Manitoba Follow-Up Study). Am J Cardiol 1994, 74:398-9.
• [17]Ness AR, Gunnell D, Hughes J, Elwood PC, Smith GD, Burr ML: Height, body mass index, and survival in men with coronary disease: follow up of the diet and reinfarction trial (DART). J Epidemiol Community Health 2002, 56:218-9.
• [18]Rosenberg CR, Shore RE, Pasternack BS: Height and mortality after myocardial infarction. J Community Health 1995, 20:335-343.
• [19]Paajanen AT, Oksala NKJ, Kuukasjärvi P, Karhunen PJ: Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis. Eur Heart J 2010, 31:1802-9.
• [20]Wang N, Zhang X, Xianget YB, Yang G, Li HL, Gao J, Cai H, Gao YT, Zheng W, Shu XO: Association of adult height and its components with mortality: a report from cohort studies of 135000 Chinese women and men. Inter J Epidemiol 2011, 40:1715-26.
• [21]Davey S, Greenwood R, Gunnell D, Sweetnam P, Yarnell J, Elwood P: Leg length, insulin resistance, and coronary heart disease risk: the Caerphilly Study. J Epidemiol Community Health 2001, 55:867-72.
• [22]Gunnell D, Whitley E, Upton M, McConnachie A, Davey S, Watt G: Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J Epidemiol Community Health 2003, 57:141-6.
• [23]Sichieri R, Siqueira KS, Pereira RA, Ascherio A: Short stature and hypertension in the city of Rio de Janeiro, Brazil. Public Health Nutr 2000, 3:77-82.
• [24]Lawlor DA, Taylor M, Smith GD, Gunnell D, Ebrahim S: Associations of components of adult height with coronary heart disease in postmenopausal women: the British Women’s Heart and Health study. Heart 2004, 90:745-9.
• [25]Schooling CM, Jiang C, Lam TH, Thomas GN, Heys M, Bmbs , Lao X, Zhang W, Adab P, Cheng KK, Leung GM: Height, its components, and cardiovascular risk among older Chinese: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Am J Public Health 2007, 97:1834-1. doi:10.2105/AJPH.2006.088096
• [26]World Health Organization (WHO, 2006): Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva: WHO; 2006.
• [27]American Heart Association (AHA, 2003)http://www.heart.org/HEARTORG/ webcite
• [28]Stockwel DH, Madhavan S, Cohen H, Gibson G, Alderman MH: The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health 1994, 84:1768-74.
• [29]Hosmer DW, Lemeshow S: Applied Logistic Regression. John Wiley & Sons Inc; 2000.
• [30]Palmer JR, Rosenberg L, Shapiro S: Stature and the risk of myocardial infarction in women. Am J Epidemiol 1990, 132:27-32.
• [31]Janghorbani M, Amini M: Association of hip circumference and height with incidence of type 2 diabetes: the isfahan Diabetes prevention Study. Acta Diabetol 2012, 49(Suppl):107-14.
• [32]Hirschhorn JN, Lindgren CM, Daly MJ, Kirby A, Schaffner SF, Burtt NP, Altshuler D, Parker A, Rioux JD, Platko J, Gaudet D, Hudson TJ, Groop LC, Lander ES, Hirschhorn JN, Lindgren CM, Daly MJ, Kirby A, Schaffner SF, Burtt NP, Altshuler D, Parker A, Rioux JD, Platko J, Gaudet D, Hudson TJ, Groop LC, Lander ES: Genomewide linkage analysis of stature in multiple populations reveals several regions with evidence of linkage to adult height. Am J Hum Genet 2001, 69:106-16.
• [33]Park HS, Yim KS, Cho SI: Gender differences in familial aggregation of obesity-related phenotypes and dietary intake pattern in Korean families. Ann Epidemiol 2004, 14:486-91.
• [34]Li JK, Ng MC, So WY, Chiu CK, Ozaki R, Tong PC, Cockram CS, Chan JC: Phenotype and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev 2006, 22:46-52.